| 摘要 |
This invention provides estrogen receptor modulators of formula I, having the structure
wherein
R 1 , R 2 , R 2a , R 3 , R 3a , and R 4 , and X as defined in the specification, or a pharmaceutically acceptable salt thereof for the treatment of inflammatory bowel diseases. |
